139 related articles for article (PubMed ID: 29145305)
1. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Li H; Yan M; Wu X; Wang Y; Huang L
Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of pyruvate kinase M2 expression in esophageal squamous cell carcinoma and its meta-analysis.
Zhang Q; Zheng S; Liu Q; Liu T; Tuerxun A; Yang L; Han X; Lu X
Transl Cancer Res; 2021 Jun; 10(6):2643-2652. PubMed ID: 35116577
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
Zhang Y; Sun Y; Zhang Q
Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
[TBL] [Abstract][Full Text] [Related]
5. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
Zhang Z; Fang T; Lv Y
World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis.
Liu B; Peng Q; Wang YW; Qiu J; Zhu J; Ma R
Front Oncol; 2023; 13():1153076. PubMed ID: 37124526
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis.
Zhang X; Xing C; Guan W; Chen L; Guo K; Yu A; Xie K
Cancer Cell Int; 2020; 20():169. PubMed ID: 32467665
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
Xu H; Liu Z; Shi H; Wang C
BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of nectin-4 in human cancers: A meta-analysis.
Liu R; Zhao K; Wang K; Zhang L; Ma W; Qiu Z; Wang W
Front Oncol; 2023; 13():1081655. PubMed ID: 36937394
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysis.
Zhu H; Zhao S; Jiao R; Wang H; Tang R; Wu X; Wang F; Ge X; Li Q; Miao L
Cancer Cell Int; 2020; 20():304. PubMed ID: 32675944
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Zhang Q; Zhou K; Liang W; Xiong W
J Int Med Res; 2020 Oct; 48(10):300060520962675. PubMed ID: 33100077
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid predicts poor prognosis in breast cancer patients: A protocol for systematic review and meta analysis.
Wu W; Chen L; Wang Y; Jin J; Xie X; Zhang J
Medicine (Baltimore); 2020 May; 99(22):e20438. PubMed ID: 32481447
[TBL] [Abstract][Full Text] [Related]
14. High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer.
Lin Y; Lv F; Liu F; Guo X; Fan Y; Gu F; Gu J; Fu L
J Cancer; 2015; 6(11):1130-9. PubMed ID: 26516361
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
Qin L; Wang Y; Yang N; Zhang Y; Zhao T; Wu Y; Jiang J
PeerJ; 2021; 9():e10859. PubMed ID: 33628641
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics.
Lai L; Chen X; Tian G; Liang R; Chen X; Qin Y; Chen K; Zhu X
Cancer Control; 2022; 29():10732748221106268. PubMed ID: 35844176
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma.
Zhang J; Zhang C; Liu X; Sun N; Zhang C; Li R; Zhang Z
Transl Cancer Res; 2020 May; 9(5):3293-3302. PubMed ID: 35117696
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.
Yavuz BB; Kilinc F; Kanyilmaz G; Aktan M
J Neurooncol; 2023 Dec; 165(3):527-533. PubMed ID: 38010491
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Wang W; Liu H; Guo W; Li P; Deng M
Transl Oncol; 2020 Nov; 13(11):100835. PubMed ID: 32702646
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of
Kuo WL; Tseng LL; Chang CC; Chen CJ; Cheng ML; Cheng HH; Wu MJ; Chen YL; Chang RT; Tang HY; Hsu YC; Lin WJ; Kao CY; Hsieh WP; Kung HJ; Wang WC
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
